Skip to main content
. 2020 Oct 8;10:16820. doi: 10.1038/s41598-020-73791-w

Table 1.

Patient characteristics between non-reversal and reversal groups after Hartmann’s procedure.

All (n = 437) Non HR (n = 310) HR (n = 127) P
Age (years) 67.7 (13.8) 70.2 (12.7) 61.6 (14.3)  < 0.001
Male 220 (50.3) 157 (50.7) 63 (49.6) 0.844
BMI (kg/m2) 22.8 (3.5) 22.6 (3.6) 23.4 (3.1) 0.058
ASA 0.034
I/II 208 (48.0) 139 (44.8) 69 (56.1)
III/IV 225(52.0) 171 (55.2) 54 (43.9)
Comorbidities 273 (62.6) 197 (63.8) 76 (59.8) 0.443
HTN 199 (45.5) 156 (50.3) 43 (33.9) 0.002
DM 83 (19.0) 68 (21.9) 15 (11.8) 0.014
Digestive disease 9 (2.1) 8 (2.6) 1 (0.8) 0.458
Pulmonolary disease 20 (4.6) 17 (5.5) 3 (2.4) 0.209
Cerebrovascular disease 47 (10.8) 41 (13.2) 6 (4.7) 0.009
Cardiologic disease 27 (6.2) 21 (6.8) 6 (4.7) 0.419
Nephrotic disease 9 (2.1) 8 (2.6) 1 (0.8) 0.458
Endocrinologic disease 29 (6.6) 22 (7.1) 7 (5.5) 0.546
Psychiatric disease 4 (0.9) 3 (1.0) 1 (0.8) 1.00
Othersa 12 (2.7) 12 (3.9) 0 (0.0) 0.022
Three or more 27 (6.2) 22 (7.1) 5 (3.9) 0.210
Previous op history 127 (29.1) 39 (30.7) 88 (28.4) 0.627
Previous cancer history 53 (12.1) 45 (14.5) 8 (6.3) 0.017
Diagnosis 0.631
Malignancy 227 (51.9) 184 (59.4) 43 (33.9)
Diverticulitis 66 (15.1) 35 (11.3) 31 (24.4)
Trauma 38 (8.7) 15 (4.8) 23 (18.1)
Fistula 7 (1.6) 6 (1.9) 1 (0.8)
Severe adhesion 3 (0.7) 6 (1.9) 1 (0.8)
Ischemia 62 (14.2) 41 (13.2) 21 (16.5)
Volvulus 7 (1.6) 6 (1.9) 1 (0.8)
Stercoral 21 (4.8) 17 (5.5) 4 (3.1)
Othersb 6 (1.4) 4 (1.3) 2 (1.6)
Tumor stage 0.003
I 8 (3.8) 3 (1.6) 5 (11.6)
II 68 (30.0) 54 (29.3) 14 (32.6)
III 97 (42.7) 77 (41.8) 20 (46.5)
IV 54 (23.8) 50 (27.2) 4 (9.3)

Data are presented as the number of patients (%) or mean (standard deviation) unless otherwise stated.

HR Hartmann’s reversal BMI body mass index, ASA American Society of Anesthesiologists, HTN hypertension, DM diabetes mellitus, op operation.

aOthers means benign prostate hyperplasia, rheumatoid arthritis.

bOthers means fecal incontinence, rectal prolapse, ileus, adhesion band.